rivoceranib
elevar therapeutics,hlb bio group
['rivoceranib', 'elevar']
it's happening today! come see our poster presentation demonstrating rivoceranib as the most selective vegfr-2 inhibitor when compared to other tkis with known activity against vegfr-2. #aacr23 
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients.